B. Gustavsson

Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI‐1)

C. Borgfeldt, B. Gustavsson, B. Casslén, 2001, International journal of cancer.

Transforming growth factor beta1 in the human endometrium. Cyclic variation, increased expression by estradiol and progesterone, and regulation of plasminogen activators and plasminogen activator inhibitor-1.

R. Willén, B. Casslén, B. Gustavsson, 1998, Biology of reproduction.

Degradation of urokinase plasminogen activator (UPA) in endometrial stromal cells requires both the UPA receptor and the low-density lipoprotein receptor-related protein/alpha2-macroglobulin receptor.

B. Angelin, B. Casslén, B. Gustavsson, 1998, Molecular human reproduction.

Human endothelial cell migration is stimulated by urokinase plasminogen activator:plasminogen activator inhibitor 1 complex released from endometrial stromal cells stimulated with transforming growth factor beta1; possible mechanism for paracrine stimulation of endometrial angiogenesis.

B. Gustavsson, B. Casslén, B. Gustavsson, 1998, Biology of reproduction.

Differential regulation of the plasminogen activator inhibitor-1 (PAI-1) gene expression by growth factors and progesterone in human endometrial stromal cells.

P. Eriksson, B. Casslén, B. Gustavsson, 1997, Molecular human reproduction.

Expression of cell membrane receptors for urokinase plasminogen activator (u-PA) in the human endometrium increases during the ovarian cycle

B. Casslén, B. Gustavsson, B. Casslén, 1991 .

Cell membrane receptors for urokinase plasminogen activator are increased in malignant ovarian tumours.

B. Gustavsson, B. Casslén, B. Gustavsson, 1991, European journal of cancer.